Evaluation of health services

Economics and Australian Health Policy

Volumn , Issue , 2020, Pages 154-171

  Carter, Rob ^a   Harris, Anthony ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85096254555     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9781003115441-8     Document Type: Chapter

References (90)

1. Abel-Smith, B. (1985) ‘Global perspective on health service financing’, Social Science and Medicine 21, 9: 95-163.
2. Arrow, KJ. (1963) ‘Uncertainty and the welfare economics of medical care’, American Economic Review, vol. 53: 941-73.
3. Arrow, K., Solow, R., Portney, P.R., Learner, E.E., Radner, R. & Schuman, H. (1993) ‘Report of the NOAA panel on contingent valuation’, Federal Register 58: 4601-14.
4. Australian Institute of Health and Welfare (AIHW) (1990) Breast Cancer Screening in Australia: Future Directions, Prevention program evaluation series no. 1, AGPS, Canberra.
5. Australian Institute of Health and Welfare (AIHW) (1991) Cervical Cancer Screening in Australia: Options for Change, Prevention Program Evaluation Series no. 2, AGPS, Canberra.
6. Berwick, D.M. and Weinstein, M.C. (1985) ‘What do patients value? Willingness to pay for ultrasound in normal pregnancy’, Medical Care 23: 881-93.
7. Birch, S. & Gafni, A. (1991) Cost Effectiveness/Utility Analysis: Do Current Decision Rules Lead Us to Where We Want to Be?, Working Paper Series no. 9-6, McMaster University, Montreal.
8. Bureau of Transport Economics (BTCE) (1984) Social Audit and Australian Transport Evaluation, AGPS, Canberra.
9. Bush, J.W., Chen, M. & Patrick, D.L. (1973) ‘Cost-effectiveness using a health status index: analysis of the New York State PKU screening programme’, in R. Berg (ed.) Health States Indexes, Hospital Research and Education Trust, Chicago.
10. Butler, J. (1992), ‘Welfare economics and cost-utility analysis’, P. Zwerfel & A.E. French III (eds) Health Economics Worldwide, Kluver Academic Publishers, Amsterdam, pp.143-57.
11. Chestnut, L.G, Keller, L.R., Lambert, W.E. & Rowe R.D. (1996) ‘Measuring heart patients’ willingness to pay for changes in angina symptoms’, Med Decision Making 16: 65-77.
12. Commonwealth Department of Health and Family Services (CDHFS) (1997) Budget 199718 Fact Sheet 7, Commonwealth of Australia Budget Papers, Canberra.
13. Commonwealth of Australia (1995) Guidelines for the Pharmaceutical Industry on Preparation of Submissions to the Pharmaceutical Benefits Advisory Committee: including major submissions involving economic analysis, CDHFS, Canberra.
14. Culyer, AJ. (1991) The Economics of Health, vols 1 and 2, Edward Elgar, London.
15. Cummings, R.G., Brookshire, D.S. & Schulze, W.D. (1986) Valuing Environmental Goods: An Assessment of the Contingent Valuation Method, Rowman & Allenheld, New Jersey.
16. Diamond, P. & Hausman, J. (1994) ‘Contingent valuation: is some number better than no number?', Journal of Economic Perspectives 8, 1: 45-64.
17. Donaldson, C, Atkinson, J., Bond, J. & Wright, K. (1988) ‘Should QALYs be programme-specific?', Journal of Health Economics 7: 239-57.
18. Donaldson, C, Shackley, P., Abdalla, M. & Miedzybrodzka, Z. (1995) ‘Willingness to pay for antenatal carrier screening for cystic fibrosis’, Health Economics 4: 439-52.
19. Drummond, M.F. (1981) Studies in Economic Appraisal in Health Care, Oxford University Press, Oxford.
20. Drummond, M.F. (1983) ‘Economic appraisal and health service decision making’, Effective Health Care 1, 1: 25-32.
21. Drummond, M.F. (1987) ‘Economic evaluation and the national diffusion and use of health technology’, Health Policy 7: 309-24.
22. Drummond, M.F. (1990) ‘Economic evaluation and health services decision making in the United Kingdom: a status report’, paper prepared for REMQUAS Association, Paris.
23. Drummond, M.F. & Davies L. (1991) ‘Economic analysis alongside clinical trials: revisiting the methodological issues, ' International Journal of Technology Assessment in Health Care 7, 4: 561-73.
24. Drummond, M.F., Lawson, K.V., Ludbrook, A. & Steele, R. (1986) Studies in Economic Appraisal in Health Care vol. 2, Oxford University Press, Oxford.
25. Drummond, M.F., Stoddart, G. & Torrance, G. (1987) Methods for the Economic Evaluation of Healthcare Programs, Oxford University Press, Oxford.
26. Drummond, M.F., Hailey, D. & Selby Smith, C. (1991) ‘Maximising the impact of health technology assessment’, in C. Selby-Smith (ed.) Economics and Health, Proceedings of the Thirteenth Australian Conference of Health Economics, Monash University, Melbourne, pp. 234-73.
27. Drummond, M.F., Brandt, A., Luce, B. & Rovira, J. (1993) ‘Standardising economic evaluation methodologies in health care: practice, problems and potential’, International Journal of Technology Assessment in Health Care 9, 1: 26-36.
28. Elliot, S.L. & Harris, A.H. (1997) ‘The methodology of cost effectiveness analysis: avoiding common pitfalls’, Medical Journal of Australia 166, 12: 636-49.
29. Gaber, A.M. & Phelps, C.E. (1995) Economic Foundations of Cost-Effectiveness Analysis, National Bureau of Economic Research, New York.
30. George, B., Harris, A.H. & Mitchell, A. (1997) ‘Reimbursement decisions and the implied value of life: cost effectiveness analysis and decisions to reimburse pharmaceuticals in Australia 1993-1996', Conference of Australian Health Economics, Melbourne.
31. Gerard, K. (1992) ‘Cost-utility in practice: a policy maker’s guide to the state of the art’, Health Policy 21: 249-79.
32. Gold, M.R., Siegel, J.E., Russell, L.B., & Weinstein, M.C. (eds) (1996) Cost-Effectiveness in Health and Medicine, Oxford University Press, Oxford.
33. Hall, J. & Mooney, G. (1990a) ‘What every doctor should know about economics, part 1: the benefits of costing’, The Medical Journal of Australia 152: 29-31.
34. Hall, J. & Mooney, G. (1990b), ‘What every doctor should know about economics, part 2: the benefits of economic appraisal’, The Medical Journal of Australia 152: 80-2.
35. Hall, J. (1993) ‘From research to action: does economic evaluation affect health policy or practice?, ' in C. Selby-Smith (ed.) Economics and Health: Proceedings of the Fifteenth Australian Conference of Health Economics, Monash University, Melbourne, pp 244-52.
36. Hanemann, W.M. (1994) ‘Valuing the environment through contingent valuation’, Journal of Economic Perspectives 8: 19-43.
37. Harris, J. (1987) ‘QALYfing the value of life’, Journal of Medical Ethics 13: 117-23.
38. Harvey, R. (1991) Making it Better: Strategies for Improving the Effectiveness and Quality of Health Services in Australia, National Health Strategy Background, Treble Press, Commonwealth Department of Human Services & Health, Canberra.
39. Hausman, J.A. (ed.) (1993) Contingent Valuation: A Critical Assessment, North-Holland, Amsterdam.
40. Hawthorne, G., Richardson, J., Osborne, R. & McNeil, H. (1997) ‘The Australian quality of life (AQoL) instrument: initial validation’, Working Paper 66, Centre for Health Program Evaluation, Monash University, Melbourne.
41. Hodgson, T.A. & Meiners, M.R. (1982) ‘Cost-of-illness methodology: a guide to current practices and procedures’, Milbank Memorial Fund Quarterly 60, 3: 429-62.
42. Johannesson, M. (1996) Theory and Methods of Economic Evaluation in Health Care, Kluwer Academic Publishers, Amsterdam.
43. Johannesson, M., Jonsson, B. & Borgquist, L. (1991) ‘Willingness to pay for antihypertensive therapy-results of a Swedish pilot survey’, Journal of Health Economics 10: 461-74.
44. Johannesson, M., Johansson, P.O. & Jonsson, B. (1992), ‘Economic evaluation of drug therapy: a review of the contingent valuation method’, PharmacoEconomics 1: 325-37.
45. Johannesson, M., Jonsson, B. & Borgquist, L. (1993), ‘Willingness to pay for antihypertensive therapy: further results’, Journal of Health Economics 12: 95-108.
46. Johnsson, B. & Weinstein, M.C. (1997) ‘Economic evaluation alongside multinational clinical trials’, International Journal of Technology Assessment in Health Care, 13(1), pp. 49-58.
47. Jones-Lee, M.W. (1989) The Economics of Safety and Physical Risk, Oxford University Press, Oxford.
48. Keeler, E. (1995) ‘Decision trees and Markov models in cost-effectiveness research’, in F.A. Sloan (ed.) Valuing Health Care: Cost, Benefits, and Effectiveness of Pharmaceuticals and Other Medical Technologies, Cambridge University Press, New York, pp 185-205.
49. Klarman, H.E., Francis, J.O.S. & Rosenthal, G. (1968) ‘Cost-effectiveness analysis applied to the treatment of chronic renal disease’, Medical Care 6: 48-54.
50. Koopmanschap, M.A. & Rutten, F.F.H. (1993) ‘Indirect costs in economic studies: confronting the confusion’, PharmacoEconomics 4: 446-54.
51. Laska E.M., Meisner, M. & Siegel, J.E. (1997) ‘Statistical inference for cost effectiveness ratios’, Health Economics 6, 3: 229-42.
52. Layard, R. & Glaister, S. (eds) (1994) Cost-Benefit Analysis, 2nd edn, Cambridge University Press, Cambridge.
53. Lindholm, L., Rosen, M. & Hellsten, G. (1994) ‘Are people willing to pay for a community-based preventive program?', International Journal Technology Assess Health Care 10: 317-24.
54. Loomes, G. & McKenzie, L. (1989) ‘Use of QALYs in health care decision making’, Social Science and Medicine, 28(4), pp. 299-308.
55. Ludbrook, A. & Mooney, GL. (1984) Economic Appraisal in the NHS: Problems and Challenges, Northern Health Economics, Health Economics Research, University of Aberdeen, Aberdeen.
56. Mishan, EJ. (1971) Cost Benefit Analysis, Unwin University Books, London.
57. Mitchell, A. (1996) ‘Update and evaluation of Australian Guidelines: government perspective’, Medical Care 34, 12: DS216-25.
58. Mooney, G. (1988) ‘Health economics and economic evaluation: an introduction’, in Australian Institute of Health (1991) Health Economics Series, no. 1. Economic evaluation of health services: report from an April 1986 workshop, AGPS, Canberra.
59. Mooney, G. (1993) Economics, Medicine and Health Care, 2nd edn, Harvester Wheat-sheaf, Hampstead, UK.
60. Mooney, G. (1996) The Consequences of Process Utility for Consequentialism in Health Economics, Paper presented at the 18th Annual Conference of the Australian Health Economists’ Society, Coffs Harbour.
61. Mooney, G, Gerard, K, Donaldson, C. & Farrar, S. (1992) ‘Priority setting in purchasing: some practical guidelines’, NAHAT Research Paper no. 6, Health Economics Research Unit, University of Aberdeen, Aberdeen.
62. National Health and Medical Research Council (NHMRC) (1995) Guidelines for the Development and Implementation of Clinical Practice Guidelines, AGPS, Canberra.
63. Neuhauser, D. & Lewicki, A.M. (1975) ‘What do we gain from the sixth stool guaiac?', New England Journal of Medicine 293: 255-58.
64. Nord, E. (1992) ‘An alternative to QALYs: the saved young life equivalent’, British Medical Journal 305: 875-7.
65. O’Brien, BJ. (1996) ‘Economic evaluation of pharmaceuticals: Frankenstein’s monster or vampire of trials?', Medical Care 34, 12: DS99-119.
66. O’Brien, B.J., Drummond, M.F. & Labelle, RJ. (1994) ‘In search of power and significance: issues in the design and analysis of stochastic cost-effectiveness studies in health care’, Medical Care 32, 2: 150-63.
67. O’Brien, BJ. et al. (1995) ‘Assessing the economic value of a new antidepressant: a willingness-to-pay approach’, PharmacoEconomics 8: 34-45.
68. Olsen, J.A. (1993) ‘Some methodological issues in economic evaluation in health care’, PhD Thesis, Department of Economics, University of Tromso.
69. Olsen, J.A. & Donaldson, C. (1998) ‘Helicopters, hearts and hips: using willingness to pay to set priorities for public sector programmes’, Social Science and Medicine, vol. 56, no. 1, pp. 1-12.
70. Peacock, S., Richardson, J. & Carter, R. (1997) ‘Setting priorities in South Australian Community Health II: marginal analysis of mental health services’, Research Report 14, Centre for Health Program Evaluation, Monash University, Melbourne.
71. Polsky, D., Click, H.A. & Willke, R. et al. (1997) ‘Confidence intervals for cost effectiveness ratios: a comparison of four methods’, Health Economics 6, 3: 243-52.
72. Richardson, J. (1991) ‘Economic assessment of health care: theory and practice’, The Australian Economic Review 1st quarter: 1-21.
73. Richardson, J. (1993) ‘Commentary’, in C. Selby-Smith (ed.) Economics and Health 1993: Proceedings of the 15th Australian Conference of Health Economists, National Centre for Health Program Evaluation, Monash University, Melbourne.
74. Richardson, J. (1994) ‘Cost utility analysis: what should be measured?', Social Science and Medicine 39, 1: 7-21.
75. Richardson, J. (1995) ‘Economic evaluation of health promotion: friend or foe?', Working Paper 50, Centre for Health Program Evaluation, Monash University, Melbourne.
76. Richardson, J., Hall, J. & Salkeld, G. (1990) ‘Cost utility analysis: the compatibility of measurement techniques and the measurement of utility through time’, in C. Selby-Smith (ed.) Economics and Health 1990: Proceedings of the 11th Annual Conference of Australian Health Economics, Public Sector Management Institute, Monash University, Melbourne.
77. Ross, J. (1995) ‘The use of economic evaluation in health care: Australian decision makers’ perceptions’, Health Policy 31: 103-10.
78. Salkeld, G. (1997) ‘Do process attributes enter the maximand for preventive goods?', in A.H. Harris (ed.) Economics and Health 1996: Proceedings of the 18th Australian Conference of Health Economists, Australian Studies in Health Service Administration no. 81, School of Health Services Management, University of New South Wales.
79. Salkeld, G., Davey, P. & Arnold, G. (1995) ‘A critical review of health-related economic evaluations in Australia: implications for health policy?', Health Policy 31:111-25.
80. Shiell, A. & Hawe, P. (1996) ‘Health promotion community development and the tyranny of individualism’, Health Economics 5: 241-7.
81. Sugden, R. & Williams, A.H. (1978) The Principles of Practical Cost-Benefit Analysis, Oxford University Press, Oxford.
82. Tolley, G.S., Kenkol, D. & Fabian R. (1994) Valuing Health for Policy: An Economic Approach, University of Chicago Press, Chicago.
83. Torrance, G.W. (1986) ‘Measurement of health-state utilities for economic appraisal: a review’, Journal of Health Economics 5: 30.
84. Viscusi, W.K. (1978) ‘Labor market valuations of life and limb: empirical evidence and policy implications’, Public Policy 26, 3, 359-86.
85. Viscusi, W.K. (1993) ‘The value of risks to life and health’, Journal of Economic Literature 1, 4: 1912-46.
86. Wagstaff, A. (1991) ‘QALYs and the equity-efficiency trade-off, Journal of Health Economics 10, 1: 21-42.
87. Weisbrod, B. (1961) Economics of Public Health: Measuring the Impact of Diseases, University of Pennsylvania, Philadelphia.
88. Williams, A.H. (1987) ‘Response: QALYfying the value of life’, Journal of Medical Ethics 13: 123.
89. Williams, A.H. (1993) ‘Cost-benefit analysis: applied welfare economics or general decision aid’, in A. Williams & E. Giardina (eds) Efficiency in the Public Sector, Edward Elgar, London.
90. Zarnke, K. et al. (1997) ‘Cost benefit analysis in the health care literature: don’t judge a study by its label’, Journal of Clinical Epidemiology 50: 813-22.